wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7
Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7
Impact of enzalutamide on patient-related outcomes in metastatic castration-resistant prostate cancer: current perspectives
P2860
Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076911-8FDF8717-4B38-4DB0-B031-2170F979D1B7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
586928e6f4f5efc243b203093b2e5184d83a217e
P2860
U.S. Food and Drug Administration Approval Summary: Enzalutamide for the Treatment of Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer.